PML plays both inimical and beneficial roles in HSV-1 replication

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 21, 2016, Pages E3022-E3028

  Xu, Pei ^a   Mallon, Stephen ^a   Roizman, Bernard ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Daxx; ICP0; Interferon; ND10; Sp100

Indexed keywords

BETA INTERFERON; DAXX PROTEIN; ICP0 PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN S 100; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VIRUS DNA; AUTOANTIGEN; CELL NUCLEUS ANTIGEN; DAXX PROTEIN, HUMAN; IMMEDIATE EARLY PROTEIN; NUCLEAR DOT PROTEIN 52, HUMAN; NUCLEAR PROTEIN; PML PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SP100 PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE; VMW110 PROTEIN, HUMAN HERPESVIRUS 1;

ANIMAL CELL; ARTICLE; CELL NUCLEUS INCLUSION BODY; CONTROLLED STUDY; GENE EXPRESSION; HEP 2 CELL LINE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS REPLICATION; WILD TYPE; ANIMAL; CHLOROCEBUS AETHIOPS; GENETICS; METABOLISM; PHYSIOLOGY; VERO CELL LINE; VIROLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, NUCLEAR; AUTOANTIGENS; CERCOPITHECUS AETHIOPS; HERPESVIRUS 1, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERFERON-BETA; INTRANUCLEAR INCLUSION BODIES; MICE; NUCLEAR PROTEINS; PROMYELOCYTIC LEUKEMIA PROTEIN; UBIQUITIN-PROTEIN LIGASES; VERO CELLS; VIRUS REPLICATION;

EID: 84971449396     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1605513113     Document Type: Article

References (50)

1. Gu H, Roizman B (2007) Herpes simplex virus-infected cell protein 0 blocks the silencing of viral DNA by dissociating histone deacetylases from the CoREST-REST complex. Proc Natl Acad Sci USA 104(43):17134-17139.
2. Knipe DM, et al. (2013) Snapshots: Chromatin control of viral infection. Virology 435(1):141-156.
3. Conn KL, Schang LM (2013) Chromatin dynamics during lytic infection with herpes simplex virus 1. Viruses 5(7):1758-1786.
4. Watson Z, Dhummakupt A, Messer H, Phelan D, Bloom D (2013) Role of polycomb proteins in regulating HSV-1 latency. Viruses 5(7):1740-1757.
5. Guise AJ, Budayeva HG, Diner BA, Cristea IM (2013) Histone deacetylases in herpesvirus replication and virus-stimulated host defense. Viruses 5(7):1607-1632.
6. Vogel JL, Kristie TM (2013) The dynamics of HCF-1 modulation of herpes simplex virus chromatin during initiation of infection. Viruses 5(5):1272-1291.
7. Everett RD, Murray J (2005) ND10 components relocate to sites associated with herpes simplex virus type 1 nucleoprotein complexes during virus infection. JVirol79(8):5078-5089.
8. Everett RD, Murray J, Orr A, Preston CM (2007) Herpes simplex virus type 1 genomes are associated with ND10 nuclear substructures in quiescently infected human fibroblasts. JVirol81(20):10991-11004.
9. Gu H, Roizman B (2003) The degradation of promyelocytic leukemia and Sp100 proteins by herpes simplex virus 1 is mediated by the ubiquitin-conjugating enzyme UbcH5a. Proc Natl Acad Sci USA 100(15):8963-8968.
10. Chelbi-Alix MK, de Thé H (1999) Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins. Oncogene 18(4): 935-941.
11. Boutell C, Sadis S, Everett RD (2002) Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro. J Virol 76(2):841-850.
12. Gu H, Zheng Y, Roizman B (2013) Interaction of herpes simplex virus ICP0 with ND10 bodies: A sequential process of adhesion, fusion, and retention. J Virol 87(18): 10244-10254.
13. Burkham J, Coen DM, Hwang CB, Weller SK (2001) Interactions of herpes simplex virus type 1 with ND10 and recruitment of PML to replication compartments. J Virol 75(5): 2353-2367.
14. Everett RD, Sourvinos G, Orr A (2003) Recruitment of herpes simplex virus type 1 transcriptional regulatory protein ICP4 into foci juxtaposed to ND10 in live, infected cells. J Virol 77(6):3680-3689.
15. Lukonis CJ, Burkham J, Weller SK (1997) Herpes simplex virus type 1 prereplicative sites are a heterogeneous population: Only a subset are likely to be precursors to replication compartments. J Virol 71(6):4771-4781.
16. Bernardi R, Pandolfi PP (2007) Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol 8(12):1006-1016.
17. Dellaire G, Bazett-Jones DP (2004) PML nuclear bodies: Dynamic sensors of DNA damage and cellular stress. BioEssays 26(9):963-977.
18. Ishov AM, et al. (1999) PML is critical for ND10 formation and recruits the PMLinteracting protein daxx to this nuclear structure when modified by SUMO-1. JCell Biol 147(2):221-234.
19. Zhong S, et al. (2000) Role of SUMO-1-modified PML in nuclear body formation. Blood 95(9):2748-2752.
20. Szostecki C, Guldner HH, Netter HJ, Will H (1990) Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J Immunol 145(12):4338-4347.
21. Dyck JA, et al. (1994) A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76(2):333-343.
22. Li H, et al. (2000) Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. Mol Cell Biol 20(5):1784-1796.
23. Koken MH, et al. (1994) The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J 13(5):1073-1083.
24. Nisole S, Stoye JP, Saïb A (2005) TRIM family proteins: Retroviral restriction and antiviral defence. Nat Rev Microbiol 3(10):799-808.
25. Dror N, et al. (2007) Interferon regulatory factor-8 is indispensable for the expression of promyelocytic leukemia and the formation of nuclear bodies in myeloid cells. J Biol Chem 282(8):5633-5640.
26. Stadler M, et al. (1995) Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene 11(12): 2565-2573.
27. Chee AV, Lopez P, Pandolfi PP, Roizman B (2003) Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects. J Virol 77(12): 7101-7105.
28. Regad T, et al. (2001) PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator. EMBO J 20(13): 3495-3505.
29. Jensen K, Shiels C, Freemont PS (2001) PML protein isoforms and the RBCC/TRIM motif. Oncogene 20(49):7223-7233.
30. Yoshida H, et al. (2007) PML-retinoic acid receptor alpha inhibits PML IV enhancement of PU.1-induced C/EBPepsilon expression in myeloid differentiation. Mol Cell Biol 27(16):5819-5834.
31. Condemine W, et al. (2006) Characterization of endogenous human promyelocytic leukemia isoforms. Cancer Res 66(12):6192-6198.
32. Gratz SJ, et al. (2014) Highly specific and efficient CRISPR/Cas9-catalyzed homologydirected repair in Drosophila. Genetics 196(4):961-971.
33. Yang H, et al. (2013) One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell 154(6):1370-1379.
34. Ma Y, Zhang L, Huang X (2014) Genome modification by CRISPR/Cas9. FEBS J 281(23): 5186-5193.
35. Liang Y, Vogel JL, Narayanan A, Peng H, Kristie TM (2009) Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency. Nat Med 15(11):1312-1317.
36. Cuchet-Lourenço D, et al. (2011) SUMO pathway dependent recruitment of cellular repressors to herpes simplex virus type 1 genomes. PLoS Pathog 7(7):e1002123.
37. Knipe DM, Cliffe A (2008) Chromatin control of herpes simplex virus lytic and latent infection. Nat Rev Microbiol 6(3):211-221.
38. McKnight JL, Kristie TM, Roizman B (1987) Binding of the virion protein mediating alpha gene induction in herpes simplex virus 1-infected cells to its cis site requires cellular proteins. Proc Natl Acad Sci USA 84(20):7061-7065.
39. Kristie TM, Roizman B (1987) Host cell proteins bind to the cis-acting site required for virion-mediated induction of herpes simplex virus 1 alpha genes. Proc Natl Acad Sci USA 84(1):71-75.
40. McKnight JL, Pellett PE, Jenkins FJ, Roizman B (1987) Characterization and nucleotide sequence of two herpes simplex virus 1 genes whose products modulate alpha-transinducing factor-dependent activation of alpha genes. J Virol 61(4):992-1001.
41. Kristie TM, LeBowitz JH, Sharp PA (1989) The octamer-binding proteins form multiprotein-DNA complexes with the HSV alpha TIF regulatory protein. EMBO J 8(13): 4229-4238.
42. Everett RD, Maul GG (1994) HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J 13(21):5062-5069.
43. Kalamvoki M, Du T, Roizman B (2014) Cells infected with herpes simplex virus 1 export to uninfected cells exosomes containing STING, viral mRNAs, and microRNAs. Proc Natl Acad Sci USA 111(46):E4991-E4996.
44. Han Z, et al. (2016) miR-H28 and miR-H29 expressed late in productive infection are exported and restrict HSV-1 replication and spread in recipient cells. Proc Natl Acad Sci USA 113(7):E894-E901.
45. Kobiler O, Lipman Y, Therkelsen K, Daubechies I, Enquist LW (2010) Herpesviruses carrying a Brainbow cassette reveal replication and expression of limited numbers of incoming genomes. Nat Commun 1:146.
46. Kobiler O, Brodersen P, Taylor MP, Ludmir EB, Enquist LW (2011) Herpesvirus replication compartments originate with single incoming viral genomes. MBio 2(6): e00278-11.
47. Kalamvoki M, Roizman B (2008) Nuclear retention of ICP0 in cells exposed to HDAC inhibitor or transfected with DNA before infection with herpes simplex virus 1. Proc Natl Acad Sci USA 105(51):20488-20493.
48. Gu H, Liang Y, Mandel G, Roizman B (2005) Components of the REST/CoREST/histone deacetylase repressor complex are disrupted, modified, and translocated in HSV-1-infected cells. Proc Natl Acad Sci USA 102(21):7571-7576.
49. Du T, Zhou G, Roizman B (2011) HSV-1 gene expression from reactivated ganglia is disordered and concurrent with suppression of latency-associated transcript and miRNAs. Proc Natl Acad Sci USA 108(46):18820-18824.
50. Flenghi L, et al. (1995) Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: Immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia. Blood 85(7):1871-1880.